Search

everythinglearnresearchcommunity

for

Search:↓

Women with PCOS should be screened for heart disease risk and manage their health to prevent it.

Polycystic ovary syndrome costs the U.S. over $4 billion a year, mainly from treating related health issues.

About 7% to 15% of Iranian women have polycystic ovary syndrome, depending on the criteria used to diagnose it.

About 2.2% of women with symptoms of high male hormones have a mild form of congenital adrenal hyperplasia, and measuring a specific hormone level can accurately diagnose it.

Different types of PCOS have different levels of metabolic problems, with the most severe type showing the highest disturbances.

About 13% of women had idiopathic hirsutism and 8.5% had polycystic ovary syndrome in a group of Iranian women.

The document suggests creating a validated score to diagnose Cushing's Syndrome and considers plasma steroid profiling as a simpler diagnostic method.

The conclusion is that small hair follicles cause baldness in macaques, and treatments like antiandrogens and minoxidil can prevent hair loss and promote regrowth.

Hormones affect prostate health and disease, with certain hormone imbalances linked to prostate cancer and benign prostatic hyperplasia.

CAH is a genetic disorder affecting cortisol production and causing hormonal imbalances, with treatment and diagnosis varying by form and symptoms.

Idiopathic hirsutism causes excessive hair growth in women, can be treated with medication and hair removal, but cannot be fully reversed.

About 19.4% of Iranian women in the study have Polycystic Ovary Syndrome, with the most common type involving irregular periods and high male hormone levels, but their heart and metabolic health is similar to women without the condition.

Androgenetic alopecia is significantly linked to metabolic syndrome.

PCOS is complex, affects many, and requires informed management and lifestyle changes.

Identifying nonclassic congenital adrenal hyperplasia and carriers of CYP21 mutations is challenging, and genetic counseling is recommended due to their prevalence.

BMI is a simple, cost-effective tool for screening obesity and related diseases.

Hair follicle organoids can help study hair biology and disorders but need improvements for wider use.

The guideline emphasizes a multidisciplinary approach and informed consent for gender-affirming hormone treatment, with regular follow-ups and individualized care.

Treating early puberty with hormone therapy may increase the risk of polycystic ovary syndrome in adults.

Innovative methods are reducing animal testing and improving biomedical research.

The document suggests more research is needed to understand the link between baldness and prostate cancer.

PCOS affects a similar percentage of Black and White women in the Southeastern United States.

Mice with autoimmune hair loss showed signs of heart problems.

Evaluate and manage androgen excess in women with a systematic approach, considering both physical and psychological impacts.

Borderline newborn screening results should be carefully evaluated to prevent delayed diagnosis of thyroid issues.

Atopic dermatitis significantly increases the risk of alopecia areata, especially in children.

Efficient PCOS screening is crucial for early detection, with lifestyle factors like fruit intake potentially aiding prevention.

Cerasus serrulata flower extracts have strong antibacterial and antioxidant effects and may help prevent hair loss.

The document concludes that personalized hormonal treatments are important for transgender individuals and more research is needed for non-binary treatments.

Early hair loss in young men is linked to higher risk of metabolic syndrome.